Imaging studies and subsequent biopsies of a liver lesion showed a foamy macrophages aggregate in a 30-year-old patient with acid sphingomyelinase deficiency (ASMD) similar to those found in Gaucher ...

Over the last decade researchers have become concerned about a possible link between a benign gynecologic lesion called endosalpingiosis (ES) and ovarian cancer. However, using a diagnostic method ...

AI-assisted colonoscopies are associated with high detection and removal rates of non-neoplastic lesions, according to a new study presented at the American College of Gastroenterology’s 2024 Annual ...

Benign mimics present either as common challenges in daily routine practice or may cause diagnostic dilemmas because some are less commonly seen and one may be less familiar in recognizing them. There ...

Please provide your email address to receive an email when new articles are posted on . Dermoscopy allows for thorough observation of morphologic features not visible to the naked eye in melanoma ...

Use of artificial intelligence (AI)-assisted colonoscopy led to a greater removal rate of exclusively benign lesions compared with colonoscopies that did not use AI, according to data analyzed from a ...

Identifying kidney cancer and differentiating between kidney cancer tumor types with a urine test is still more of a fond wish than a reality, but several strategies that are in late-stage development ...

- Poster Presentation Showcases Patient Motivation to Seek a New Procedure to Clear Common Benign Lesions “We see many aesthetic patients with visible skin lesions that have a substantial impact on ...

PHILADELPHIA — Artificial intelligence–assisted colonoscopy (AIAC) with computer-aided detection (CADe) technology may improve adenoma detection rate (ADR), but it’s also associated with higher ...

Lesions and lumps often appear in the mouth, but many of them are benign. While some may need to be removed, many don’t require any treatment at all. Benign oral cavity tumors are essentially ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation™ (NPS™) technology, today ...